EGFR and PDGFR crosstalk may dictate the resistance to EGFR therapy in bladder cancer

被引：1
|
作者：
Adam, L.
Black, P.
Brown, G.
Munsell, M.
Kassouf, W.
Nicola, P.
Dinney, C.
McConkey, D.
Bar-Eli, M.
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Urol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Biostat, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Canc Biol, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70211-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] Targeting EGFR in bladder cancer
    Villares G.J.
    Zigler M.
    Blehm K.
    Bogdan C.
    McConkey D.
    Colin D.
    Bar-Eli M.
    World Journal of Urology, 2007, 25 (6) : 573 - 579
  • [2] Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy
    Kuwai, Toshio
    Nakamura, Toru
    Sasaki, Takamitsu
    Kitadai, Yasuhiko
    Kim, Jang-Seong
    Langley, Robert R.
    Fan, Dominic
    Wang, Xuemei
    Do, Kim-Anh
    Kim, Sun-Jin
    Fidler, Isaiah J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (04) : 477 - 489
  • [3] Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy
    Toshio Kuwai
    Toru Nakamura
    Takamitsu Sasaki
    Yasuhiko Kitadai
    Jang-Seong Kim
    Robert R. Langley
    Dominic Fan
    Xuemei Wang
    Kim-Anh Do
    Sun-Jin Kim
    Isaiah J. Fidler
    Clinical & Experimental Metastasis, 2008, 25 : 477 - 489
  • [4] EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
    Wang, Anbang
    Jiang, Aimin
    Gan, Xinxin
    Wang, Zheng
    Huang, Jinming
    Dong, Kai
    Liu, Bing
    Wang, Linhui
    Chen, Ming
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [5] EGFR mutations determine EGFR-MET crosstalk and MET inhibition in lung cancer
    Lee, Richard
    Ortiz-Zapater, Elena
    Weitsman, Gregory
    Fruhwirth, Gilbert
    Owen, Will
    Ng, Tony
    Santis, George
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
    Bianco, R
    Troiani, T
    Tortora, G
    Ciardiello, F
    ENDOCRINE-RELATED CANCER, 2005, 12 : S159 - S171
  • [7] Overcoming therapy resistance in EGFR-mutant lung cancer
    Passaro, Antonio
    Janne, Pasi A.
    Mok, Tony
    Peters, Solange
    NATURE CANCER, 2021, 2 (04) : 377 - 391
  • [8] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
    Zhao, Ben
    Wang, Lu
    Qiu, Hong
    Zhang, Mingsheng
    Sun, Li
    Peng, Ping
    Yu, Qianqian
    Yuan, Xianglin
    ONCOTARGET, 2017, 8 (03) : 3980 - 4000
  • [9] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [10] Molecular mechanisms of EGFR therapy resistance in breast cancer cells
    Castillo-Pichardo, Linette
    Borrero-Garcia, Luis D.
    Redis, Roxana S.
    Calin, George A.
    Cubano, Luis A.
    Dharmawardhane, Suranganie
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
12345